Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers
Robert H. Shoemaker(National Cancer Institute), Clinton J. Grubbs(University of Alabama at Birmingham)
Cited by 6
Related Papers
No related papers found
Powered by citation graph analysis